Medication Monitoring of Anti-infection Drugs in a Patient with Lupus Nephritis Complicated with Com-munity Acquired Pneumonia
- VernacularTitle:狼疮性肾炎并发社区获得性肺炎患者的抗感染用药监护
- Author:
Ronglian HE
;
Aimin MA
;
Jiang HE
- Publication Type:Journal Article
- Keywords:
Clinical pharmacists;
Pharmaceutical care;
Community acquired pneumonia;
Lupus nephritis
- From:
China Pharmacist
2015;(4):628-630
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the value of clinical pharmacists in the anti-infection practice for a patient with lupus nephritis complicated with community-acquired pneumonia(severe). Methods:Clinical pharmacists carried out medication monitoring in the entire treatment process of a patient with lupus nephritis complicated with community-acquired pneumonia( severe)in the clinical front line. Depending on the pharmaceutical knowledge,clinical pharmacists assisted physicians to make out the optimal medication and ad-justed the medication according to the patient′s conditions. Results:Moxifloxacin and piperacillin sodium /tazobactam sodium could ef-fectively control the severe pulmonary infection of the patient with lupus nephritis and avoid the potential risk of recurrence or aggrava-tion of lupus nephritis. Conclusion:The choice of antimicrobial agents for the special populations should consider not only the antibac-terial spectrum and antibacterial activity,but also the individual characteristics of patients and pharmacokinetics of drugs in order to im-prove the safety and effectiveness of medication.
